Lowering ammonia in acute-on-chronic liver failure
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether lowering ammonia levels in people with advanced liver disease can prevent serious liver complications. It uses special treatments to reduce ammonia, aiming to improve outcomes without causing confusion or other brain-related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have acute-on-chronic liver failure (ACLF) that is not severe (grade I or II).
- Your blood ammonia level is high (135 µg/dL or more).
- You are willing to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting midodrine early can help control or prevent fluid buildup in the belly (ascites) and related problems in people with acute-on-chronic liver failure. If it works, it may reduce the need for more intensive treatments.
This study looks at patients with cirrhosis who are admitted to the intensive care unit with acute-on-chronic liver failure. It aims to understand and improve care for this serious condition using a standard scoring system.
This trial tests a new drug called AS1501 for people with acute-on-chronic liver failure (a sudden worsening of chronic liver disease). It aims to see if the drug can help improve liver function and reduce the need for a liver transplant. You may be eligible if you are in the early or middle stage of this condition and have a specific blood marker (high TRAIL level).
This trial tests an experimental drug for people with severe alcoholic hepatitis that did not improve with steroids. Participants should have a moderate level of organ failure, but not require a breathing tube or kidney dialysis.
This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.
This trial tests whether taking the antibiotic rifaximin just before and after a living-donor liver transplant can help prevent early problems with the new liver. It may be an option for adults having this surgery at the study hospital.
Hear when a new Acute-On-Chronic Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.